This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Oncology  • Head & Neck Cancer  • Endocrine Disease of Head & Neck  • Neoplasms of Head & Neck  • Surgery  • Surgical Oncology  • Endocrine Diseases  • Thyroid/ Parathyroid Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Sergio Zuniga, MD; Alvaro Sanabria, MD, MSc, PhD

Arch Otolaryngol Head Neck Surg. 2009;135(11):1087-1091.

Objective  To assess the disease-free survival results of prophylactic central neck dissection for papillary thyroid carcinoma preoperatively staged as N0.

Design  Inception cohort.

Setting  Head and neck surgery unit at a national oncologic center.

Patients  Patients with a histologically confirmed diagnosis of stage N0 papillary thyroid cancer but no previous oncologic treatment, no recurrent tumor, and no distant metastasis.

Intervention  Central neck dissection intended as curative treatment.

Main Outcome Measure  Disease-free survival. Demographic, clinical, therapeutic, pathologic, and neck recurrence information was also collected.

Results  A total of 266 patients were included. Mean (SD) follow-up time was 6.9 (4.3) years. Ninety percent of patients had a follow-up longer than 2 years. Prophylactic central neck dissection was performed in 136 patients (51.3%). Of those patients who underwent central neck dissection, 112 had metastatic lymph nodes (82.3%). Neck recurrence occurred in 45 patients (16.9%). Overall, 5-year neck disease–free survival was 86.8%; it was 88.2% in the central neck dissection group vs 85.6% in the group that did not undergo central neck dissection (P = .72). In the multivariate analysis, factors related to central neck dissection were macroscopic extrathyroidal extension (odds ratio [OR], 2.12; 95% confidence interval [CI], 1.19-3.79) and multifocality (OR, 3.96; 95% CI, 2.08-7.53). In Cox multivariate analysis for disease-free survival, central neck dissection did not show any significant effect.

Conclusion  Prophylactic central neck dissection did not show any advantage in the rate of neck recurrence in patients with N0 clinical stage disease.

Author Affiliations: Head and Neck Surgery Unit, Department of Surgery, Clinica Las Americas, Medellin, Colombia (Dr Zuniga); and Department of Surgery, School of Medicine, Universidad de La Sabana–Fundacion Abood Shaio, Bogota, Colombia (Dr Sanabria). Dr Zuniga was formerly with the National Cancer Institute, Bogota.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?